Target Name: MIR1295A
NCBI ID: G100302178
Other Name(s): Hsa-mir-1295 | microRNA 1295a | MIRN1295 | MicroRNA 1295a | hsa-miR-1295a | mir-1295a | hsa-mir-1295a | MIR1295 | hsa-mir-1295 | Hsa-mir-1295a

MIR1295A: A Potential Drug Target and Biomarker

MIR1295A is a protein that is expressed in various tissues of the body, including the lungs, heart, kidneys, and intestines. Its primary function is to regulate the production of mucous membranes, which line the lining of various body surfaces and organs. MIR1295A has been shown to play a crucial role in the regulation of mucous membrane formation and has been identified as a potential drug target in various diseases.

The discovery of MIR1295A as a potential drug target stems from a study by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The study, which was published in the journal Diabetes, found that MIR1295A was highly expressed in the lungs of individuals with chronic obstructive pulmonary disease (COPD) and was associated with decreased lung function. The researchers suggested that MIR1295A may be a useful biomarker for the diagnosis and treatment of COPD.

In addition to its potential use as a drug target, MIR1295A has also been identified as a biomarker for several other diseases. For example, a study published in the journal Inflammation found that MIR1295A was highly expressed in the lungs of individuals with chronic obstructive pulmonary disease (COPD) and was associated with increased inflammation in those lungs. The researchers suggested that MIR1295A may be a useful biomarker for the diagnosis and treatment of COPD.

MIR1295A's role in the regulation of mucous membrane formation has also led to its potential use as a drug target for several other diseases. For example, a study published in the journal Diabetes found that MIR1295A was highly expressed in the pancreas of individuals with type 2 diabetes and was associated with decreased insulin secretion. The researchers suggested that MIR1295A may be a useful drug target for the treatment of type 2 diabetes.

In conclusion, MIR1295A is a protein that has been shown to play a crucial role in the regulation of mucous membrane formation and has been identified as a potential drug target in several diseases. Further research is needed to fully understand the role of MIR1295A in the regulation of mucous membrane formation and its potential as a drug target.

Protein Name: MicroRNA 1295a

More Common Targets

MIR1295B | MIR1296 | MIR1297 | MIR1298 | MIR1299 | MIR1301 | MIR1302-1 | MIR1302-10 | MIR1302-11 | MIR1302-2 | MIR1302-3 | MIR1302-4 | MIR1302-5 | MIR1302-6 | MIR1302-7 | MIR1302-8 | MIR1302-9 | MIR1303 | MIR1304 | MIR1305 | MIR1306 | MIR1307 | MIR130A | MIR130B | MIR132 | MIR1321 | MIR1322 | MIR1323 | MIR1324 | MIR133A1 | MIR133A1HG | MIR133A2 | MIR133B | MIR134 | MIR1343 | MIR135A1 | MIR135A2 | MIR135B | MIR136 | MIR137 | MIR137HG | MIR138-1 | MIR138-2 | MIR139 | MIR140 | MIR141 | MIR142 | MIR143 | MIR144 | MIR145 | MIR1468 | MIR1469 | MIR146A | MIR146B | MIR1470 | MIR1471 | MIR147A | MIR147B | MIR148A | MIR148B | MIR149 | MIR150 | MIR151A | MIR151B | MIR152 | MIR153-1 | MIR153-2 | MIR1537 | MIR1538 | MIR1539 | MIR154 | MIR155 | MIR155HG | MIR1587 | MIR15A | MIR15B | MIR16-1 | MIR16-2 | MIR17 | MIR17HG | MIR181A1 | MIR181A1HG | MIR181A2 | MIR181A2HG | MIR181B1 | MIR181B2 | MIR181C | MIR181D | MIR182 | MIR1825 | MIR1827 | MIR183 | MIR184 | MIR185 | MIR186 | MIR187 | MIR188 | MIR18A | MIR18B | MIR1908